Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria
NCT02238249
·
clinicaltrials.gov ↗
COMPLETED
Status
122
Enrollment
INDUSTRY
Sponsor class
Conditions
Urticaria
Interventions
DRUG:
Alesion®
Sponsor
Boehringer Ingelheim